Login / Signup
Zengxia Li
ORCID
Publication Activity (10 Years)
Years Active: 2023-2023
Publications (10 Years): 1
Top Topics
Cell Surface
Endoplasmic Reticulum
Childhood Cancer
Escherichia Coli
Top Venues
Molecular cancer therapeutics
</>
This page only lists publications with an associated author ORCID identifier.
Publications
</>
Wenlong Xu
,
Yuqi Wang
,
Na Zhang
,
Xiaofeng Lin
,
Di Zhu
,
Cheng Shen
,
Xiaobo Wang
,
Haiyang Li
,
Jinjiang Xue
,
Qian Yu
,
Xinyi Lu
,
Lu Zhou
,
Qing-Li He
,
Zhijun Tang
,
Shaodan He
,
Jian-Jun Fan
,
Jianbo Pan
,
Jiang-Jiang Tang
,
Wei Jiang
,
Mingliang Ye
,
Fanghui Lu
,
Zengxia Li
,
Yong-Jun Dang
The antipsychotic drug penfluridol inhibits N-linked glycoprotein processing and enhances T-cell-mediated tumor immunity.
Molecular cancer therapeutics
(2023)